Work

Evaluation of irofulven (MGI-114) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology Group

Year: 2004

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1023/b:drug.0000026262.77502.31

Authors: Russell J. Schilder, John A. Blessing, Michael L. Pearl, Peter G. Rose

Institutions: Fox Chase Cancer Center, Roswell Park Comprehensive Cancer Center, State University of New York, Stony Brook School, Stony Brook University, Case Western Reserve University

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G1950154987, GYNECOLOGIC ONCOLOGY GROUP STATISTICAL AND DATA CENTER, Gynecologic Oncology Group, G70736214

OpenAlex ID: W1978250626

FWCI: 2.156

Cites: 14

Cited by: 28

Related to: 10